Keeping you up to date with all the latest movers and shakers in the Micro-cap and penny stock industry, we sometimes veer off into small-cap stocks that have momentum or look like cheap stocks. These 7 Nasdaq listed stocks are worth watching to start the month off; 4 are momentum stocks while the other 3 are cheap stocks. All of them offer some strong potential to turn a profit before Independence Day.
Looking for Hot Penny Stocks? Click here and get Alerts on the Best Penny Stocks FREE.
Microvision Inc. (Nasdaq: MVIS)
MVIS is set to open the month at $2.65. The stock is currently priced 42.78% above the 50 day moving average, -9.21% below the 200 day moving average, -76.00% below the 52-week high of $11.04, and 138.74% above the 52-week low of $1.11. MVIS held a very tight trading range on Thursday as news of a $4 million purchase order from Pioneer spread, gapping the stock up 30% at the open reaching a high of $2.96 in the last trading session. MVIS is looking ready to tackle the $3 level.
Synta Pharmaceuticals Corp. (Nasdaq: SNTA)
SNTA is set top open the month at $4.81. The stock is currently priced 17.75% above the 50 day moving average, 8.11% above the 200 day moving average, -16.20% below the 52-week high of $5.74, and 59.27%% above the 52-week low of $3.02. Cancer therapy potential triggers a rally for SNTA. Recently the 13 day moving average crossed the 20 day moving average and is now set to cross the 50 day moving average, bullish signs in our opinion. Look for a possible pullback entry point in the morning, but dont be surprised if we see this move over $5 with little or no pullback.
ARNA Arena Pharmaceuticals, Inc. (Nasdaq: ARNA)
ARNA is set top open the month at $6.69. The stock is currently priced 66.81% above the 50 day moving average, 171.60% above the 200 day moving average, -4.70% below the 52-week high of $7.02, and 443.90% above the 52-week low of $1.23. June 27th, mark your calendars, is the FDA date for a thumbs up or thumbs down, although usually the decision goes in line with the panel recommendations, which was to approve it. Although some analysts believe the stock price already accounts for an FDA approval, and they may be right, it doesn’t mean the stock is going to stay quiet till then. Traders have already seen a pullback and 2nd rally start up on ARNA. Keep a close eye on the $7.01 recent high.
Xenoport, Inc. (Nasdaq: XNPT)
XNPT is set top open the month at $5.88. The stock is currently priced 17.16% above the 50 day moving average, 31.74% above the 200 day moving average, -27.14% below the 52-week high of $8.07, and 69.94% above the 52-week low of $3.46. Traders continue to see some tight trading on XNPT with the possibility of a dip entry if the 13 day moving average support line doesn’t hold. Keep watch for news as that could be the catalyst to break this channel.
MannKind Corp. (Nasdaq: MNKD)
MNKD is set top open the month at $1.82. The stock is currently priced -8.24% below the 50 day moving average, -25.31% below the 200 day moving average, -57.67% below the 52-week high of $4.30, and 15.92% above the 52-week low of $1.57. Results published in Blood, the official journal of the American Society of Hematology, confirm that inhibition of the IRE1α-XBP1 pathway impacts the survival of myeloma cells, suggesting a promising therapeutic option in multiple myeloma. The pre-clinical study, conducted by researchers at Dana-Farber Cancer Institute in collaboration with MNKD, confirm that blocking the XBP1 arm of the unfolded protein response with MNKD‘s novel, first-in-class IRE1a RNase domain inhibitor, MKC-3946, alone or in combination with bortezomib or 17AAG, inhibited growth in multiple myeloma cells, while leaving normal cells intact.
Micronetics Inc. (Nasdaq: NOIZ)
NOIZ is set top open the month at $7.50. The stock is currently priced -4.64% below the 50 day moving average, -3.80% below the 200 day moving average, -18.36% below the 52-week high of $9.19, and 72.81% above the 52-week low of $4.34. On its Q4 fiscal 2012, NOIZ posted net sales of $12,258,367, a 31% increase year over year, and net income of $863,123 or $0.18 per diluted share, compared to net income of $444,137 or $0.10 per diluted share in the same period the prior year.
Ossen Innovation Co., Ltd. (Nasdaq: OSN)
OSN is set top open the month at $0.95. The stock is currently priced -4.76% below the 50 day moving average, -6.59% below the 200 day moving average, -76.25% below the 52-week high of $4.00, and 31.94% above the 52-week low of $0.72. OSN reported that its Board of Directors authorized the extension of its repurchase plan of up to 500 thousand shares of OSN‘s American Depositary Receipts (“ADSs”) , or approximately 8.1%, of the outstanding ADSs of the Company, for an additional twelve months to May 31, 2013. Repurchases are authorized to be made by OSN from time to time at the prevailing market price on the open market, and/or in negotiated transactions off the market from time to time as market conditions warrant in accordance with applicable requirements of Rule 10b5-1 and/or Rule 10b-18 under the U.S. Securities Exchange Act of 1934, as amended. Shares repurchased will be held in Treasury.
Bottom Line: These 7 stocks, 4 momentum stocks and 3 cheap stocks, should keep you busy over the course of the month while you wait for us to send out an alert on the best penny stocks traders can get.
Here is your opportunity to subscribe to the most elite penny stock newsletter.
Sign up with your email address now & get ready to make HUGE PROFITS on stocks that RUN.
(We are 100% Anti-Spam and will never rent or sell your information)Share